We identified divergent UPR signaling between malignant CTCL and normal CD4+ T cells that involves the hyper-responsiveness of Hsp70 family members, HSPA5 and HSPA6. This evidence concerns the gene CD4 and primary cutaneous T-cell non-Hodgkin lymphoma.